We recognize you are faced with a changing regulatory environment, evolving customer expectations and the need to improve the profitability of your business. DuBois R&D teams have your interests in mind; we focus on developing products and processes that address your immediate and long term needs.
DuBois continually develops new products, improves existing products to improve efficiency in your operations. Our R&D teams assist customers in solving problems with a product, application or process. DuBois keeps an eye on industry and stays up with the latest developments in new raw materials, equipment, processes and environmental issues. This helps to keep all of us on the leading edge of technology.
Customer Driven Chemistry
DuBois specializes in custom product development. We create products and processes to help you solve your specific manufacturing, cleaning or treatment challenges. With eight Technical Centers of Excellence across North America, we have resources near your operation to facilitate collaboration.
DuBois technology teams understand the concept of Total Cost of Ownership. Our Chemists, Engineers and Technical Sales professionals are trained in lean concepts and will seek carbon, water and environmental footprint reductions in your processes. Our applied resources result in a higher ROI for you and your facilities.
Trade Expo / 12.15.22
DuBois Chemicals will be exhibiting at TAPPICON in Atlanta, GA at the Cobb Galleria April 22-26, 2023
Recent Events / 10.02.18
The acquisition of the Water Treatment Solutions division of Triwater Holdings LLC, and its Klenzoid, Eldon Water, Chemco Products and Nashville Chemical brands, expands DuBois position in Canada and enhances our solutions for the institutional, light industrial, food and beverage and natural resources markets.
Recent Events / 06.18.18
IPAC Holdings (Innovative People Advancing Chemistry) joins DuBois. IPAC and Power Chemicals supports the needs of customers in the hard rock mining, coal, primary metals, bulk terminal, pulp and paper and water treatment markets.